Symbols / CNTN Stock $3.23 +0.00% Canton Strategic Holdings, Inc.

Healthcare • Biotechnology • United States • NCM
CNTN (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: SMA 50: SMA 200:
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Healthcare
Industry Biotechnology
CEO Mr. Mark Wendland
Exch · Country NCM · United States
Market Cap 183.00M
Enterprise Value 165.97M
Income -35.92M
Sales
FCF (ttm) -9.02M
Book/sh 10.72
Cash/sh 0.30
Employees 12
Insider 10d
IPO Jan 12, 2022
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 0.00%
P/E
Forward P/E
PEG
P/S
P/B 0.30
P/C
EV/EBITDA
EV/Sales
Quick Ratio 5.18
Current Ratio 5.29
Debt/Eq
LT Debt/Eq
EPS (ttm) -1.12
EPS next Y
EPS Growth
Revenue Growth
EPS Gr Q/Q
Rev Gr Q/Q
Earnings (next)
Earnings (prior)
ROA -4.81%
ROE -17.99%
ROIC
Gross Margin 0.00%
Oper. Margin 0.00%
Profit Margin 0.00%
Shs Outstand 56.66M
Shs Float 49.72M
Insider Own 23.84%
Instit Own 18.47%
Short Float 6.61%
Short Ratio 5.83
Short Interest 3.61M
52W High 9.08
vs 52W High -64.43%
52W Low 1.08
vs 52W Low 198.80%
Beta 1.60
Impl. Vol.
Rel Volume 0.47
Avg Volume 661.03K
Volume 308.72K
Target (mean)
Tgt Median
Tgt Low
Tgt High
# Analysts
Recom None
Prev Close $3.23
Price $3.23
Change 0.00%
About

Canton Strategic Holdings, Inc. focuses on leveraging Canton Coin and supporting the Canton network to advance institutional blockchain adoption and the digitization of financial markets. The company also involved in research and development of GV104, a buccal film technology, which has completed Phase 1 trial for respiratory and/or nervous system depression in military personnel and chemical incident responders; and GV023, an oral formulation of infliximab, addresses a critical limitation of the IV gold standard by eliminating the treatment burden of repeated intravenous infusions. The company was formerly known as Tharimmune, Inc. and changed its name to Canton Strategic Holdings, Inc. in February 2026. Canton Strategic Holdings, Inc. was founded in 2017 and is based in Red Bank, New Jersey.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus Mean price target
2. Current target Latest analyst target
3. DCF / Fair value Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$3.23
Low
High
Mean
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2025-06-23 ANDERSON KELLY J Director 6,300 $0.00 $0
2025-06-20 APPAJOSYULA SIREESH Chief Executive Officer 61,496 $1.42 $90,973
2025-06-20 PARIKH SANAM Director 1,000 $1.45 $1,450
2025-06-20 GRAVITAS CAPITAL LP Officer, Director and Beneficial Owner 337,838 $1.48 $500,000
2025-05-15 PARIKH SANAM Director 770 $1.30 $1,001
2024-12-19 MILBY RANDY Chief Executive Officer 4,600 $2.12 $9,752
2024-11-13 APPAJOSYULA SIREESH Chief Operating Officer 5,000 $2.02 $10,096
2024-10-08 MILBY RANDY Chief Executive Officer 2,500 $2.08 $5,221
2024-10-08 APPAJOSYULA SIREESH Chief Operating Officer 5,000 $1.93 $9,650
2024-10-08 APPAJOSYULA SIREESH Chief Operating Officer 5,000 $1.93 $9,650
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
0.00
0.00
0.00
0.00
Operating Revenue
0.00
0.00
0.00
0.00
Operating Expense
20.11
+61.71%
12.43
+31.50%
9.46
+37.39%
6.88
Research And Development
3.07
-51.91%
6.39
+79.57%
3.56
+56.23%
2.28
Selling General And Administration
17.03
+181.91%
6.04
+2.48%
5.90
+28.07%
4.60
General And Administrative Expense
17.03
+181.91%
6.04
+2.48%
5.90
+28.07%
4.60
Other Gand A
17.03
+181.91%
6.04
+2.48%
5.90
+28.07%
4.60
Total Expenses
20.11
+61.71%
12.43
+31.50%
9.46
+37.39%
6.88
Operating Income
-20.11
-61.71%
-12.43
-31.50%
-9.46
-37.39%
-6.88
Total Operating Income As Reported
-20.11
-61.71%
-12.43
-31.50%
-9.46
-37.39%
-6.88
EBITDA
-42.08
-245.33%
-12.18
-30.97%
-9.30
-35.17%
-6.88
Normalized EBITDA
-42.08
-245.33%
-12.18
-30.97%
-9.30
-35.17%
-6.88
EBIT
-42.08
-245.33%
-12.18
-30.97%
-9.30
-35.17%
-6.88
Total Unusual Items
Total Unusual Items Excluding Goodwill
Special Income Charges
Restructuring And Mergern Acquisition
Net Income
-35.92
-194.45%
-12.20
-30.89%
-9.32
-9.98%
-8.47
Pretax Income
-42.10
-245.18%
-12.20
-30.89%
-9.32
-9.98%
-8.47
Net Non Operating Interest Income Expense
0.01
-94.47%
0.24
+73.53%
0.14
+108.55%
-1.59
Interest Expense Non Operating
0.03
+107.14%
0.01
-17.09%
0.02
-98.96%
1.59
Net Interest Income
0.01
-94.47%
0.24
+73.53%
0.14
+108.55%
-1.59
Interest Expense
0.03
+107.14%
0.01
-17.09%
0.02
-98.96%
1.59
Interest Income Non Operating
0.04
-83.43%
0.25
+63.73%
0.15
0.00
Interest Income
0.04
-83.43%
0.25
+63.73%
0.15
0.00
Other Income Expense
-22.01
Other Non Operating Income Expenses
-22.01
Tax Provision
-6.19
0.00
Tax Rate For Calcs
0.00
0.00
0.00
0.00
Tax Effect Of Unusual Items
0.00
0.00
0.00
0.00
Net Income Including Noncontrolling Interests
-35.92
-194.45%
-12.20
-30.89%
-9.32
-9.98%
-8.47
Net Income From Continuing Operation Net Minority Interest
-35.92
-194.45%
-12.20
-30.89%
-9.32
-9.98%
-8.47
Net Income From Continuing And Discontinued Operation
-35.92
-194.45%
-12.20
-30.89%
-9.32
-9.98%
-8.47
Net Income Continuous Operations
-35.92
-194.45%
-12.20
-30.89%
-9.32
-9.98%
-8.47
Normalized Income
-35.92
-194.45%
-12.20
-30.89%
-9.32
-9.98%
-8.47
Net Income Common Stockholders
-35.92
-194.45%
-12.20
-30.89%
-9.32
-9.98%
-8.47
Diluted EPS
-1.12
+88.10%
-9.41
+91.21%
-107.02
+61.89%
-280.80
Basic EPS
-1.12
+88.10%
-9.41
+91.21%
-107.02
+61.89%
-280.80
Basic Average Shares
32.05
+2372.39%
1.30
+1388.64%
0.09
+188.54%
0.03
Diluted Average Shares
32.05
+2372.39%
1.30
+1388.64%
0.09
+188.54%
0.03
Diluted NI Availto Com Stockholders
-35.92
-194.45%
-12.20
-30.89%
-9.32
-9.98%
-8.47
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Assets
519.15
+13849.46%
3.72
-66.00%
10.95
+63.66%
6.69
Current Assets
17.39
+367.16%
3.72
-66.00%
10.95
+63.66%
6.69
Cash Cash Equivalents And Short Term Investments
17.03
+378.53%
3.56
-67.45%
10.94
+67.96%
6.51
Cash And Cash Equivalents
17.03
+378.53%
3.56
-67.45%
10.94
+67.96%
6.51
Cash Financial
17.03
+378.53%
3.56
-67.45%
10.94
+67.96%
6.51
Prepaid Assets
Current Deferred Assets
0.00
-100.00%
0.12
0.00
0.00
Other Current Assets
0.35
+680.59%
0.05
+309.95%
0.01
-93.80%
0.18
Total Non Current Assets
501.76
0.00
0.00
0.00
Goodwill And Other Intangible Assets
501.76
0.00
Other Intangible Assets
501.76
Total Liabilities Net Minority Interest
121.22
+4921.60%
2.41
+33.00%
1.82
+58.52%
1.14
Current Liabilities
3.29
+36.14%
2.41
+33.00%
1.82
+58.52%
1.14
Payables And Accrued Expenses
3.29
+36.14%
2.41
+33.00%
1.82
+58.52%
1.14
Payables
1.09
+0.06%
1.09
+19.93%
0.91
-4.81%
0.95
Accounts Payable
1.09
+0.06%
1.09
+19.93%
0.91
-4.81%
0.95
Current Accrued Expenses
2.20
+65.83%
1.32
+46.10%
0.91
+375.92%
0.19
Current Debt And Capital Lease Obligation
Current Debt
Other Current Borrowings
Other Current Liabilities
Total Non Current Liabilities Net Minority Interest
117.93
0.00
0.00
0.00
Long Term Debt And Capital Lease Obligation
Long Term Debt
Non Current Deferred Liabilities
117.93
0.00
Non Current Deferred Taxes Liabilities
117.93
0.00
Stockholders Equity
397.93
+30330.80%
1.31
-85.68%
9.13
+64.72%
5.54
Common Stock Equity
397.93
+30330.80%
1.31
-85.68%
9.13
+64.72%
5.54
Capital Stock
0.00
+1774.24%
0.00
+122.47%
0.00
+93.48%
0.00
Common Stock
0.00
+1774.24%
0.00
+122.47%
0.00
+93.48%
0.00
Preferred Stock
0.00
0.00
0.00
0.00
Share Issued
37.39
+1793.94%
1.97
+152.14%
0.78
+2429.85%
0.03
Ordinary Shares Number
37.39
+1794.16%
1.97
+152.19%
0.78
+2449.00%
0.03
Treasury Shares Number
0.00
+0.00%
0.00
+1.65%
0.00
+0.00%
0.00
Additional Paid In Capital
470.81
+1129.96%
38.28
+12.90%
33.90
+61.47%
21.00
Retained Earnings
-72.82
-97.33%
-36.90
-49.38%
-24.70
-60.57%
-15.38
Treasury Stock
0.07
+0.00%
0.07
+0.00%
0.07
+0.00%
0.07
Total Equity Gross Minority Interest
397.93
+30330.80%
1.31
-85.68%
9.13
+64.72%
5.54
Total Capitalization
397.93
+30330.80%
1.31
-85.68%
9.13
+64.72%
5.54
Working Capital
14.10
+978.25%
1.31
-85.68%
9.13
+64.72%
5.54
Invested Capital
397.93
+30330.80%
1.31
-85.68%
9.13
+64.72%
5.54
Total Debt
Net Debt
Net Tangible Assets
-103.83
-8040.59%
1.31
-85.68%
9.13
+64.72%
5.54
Tangible Book Value
-103.83
-8040.59%
1.31
-85.68%
9.13
+64.72%
5.54
Dueto Related Parties Current
0.00
Interest Payable
0.00
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
-16.13
-47.94%
-10.90
-49.34%
-7.30
-11.32%
-6.56
Cash Flow From Continuing Operating Activities
-16.13
-47.94%
-10.90
-49.34%
-7.30
-11.32%
-6.56
Net Income From Continuing Operations
-35.92
-194.45%
-12.20
-30.89%
-9.32
-9.98%
-8.47
Other Non Cash Items
0.10
+388.67%
0.02
-94.13%
0.35
-79.21%
1.68
Stock Based Compensation
2.88
+305.15%
0.71
-14.61%
0.83
+3.89%
0.80
Deferred Tax
-6.19
0.00
Deferred Income Tax
-6.19
0.00
Operating Gains Losses
22.01
Gain Loss On Sale Of PPE
22.01
0.00
Change In Working Capital
0.99
+74.67%
0.56
-32.54%
0.84
+247.09%
-0.57
Change In Prepaid Assets
-0.31
-800.17%
-0.03
-120.49%
0.17
+255.51%
-0.11
Change In Payables And Accrued Expense
1.29
+116.13%
0.60
-10.62%
0.67
+245.14%
-0.46
Change In Accrued Expense
1.07
+156.55%
0.42
-41.64%
0.72
+694.10%
-0.12
Change In Payable
0.22
+22.86%
0.18
+494.29%
-0.05
+86.54%
-0.34
Change In Account Payable
0.22
+22.86%
0.18
+494.29%
-0.05
+67.47%
-0.14
Investing Cash Flow
-77.57
0.00
0.00
0.00
Cash Flow From Continuing Investing Activities
-77.57
0.00
Capital Expenditure
-77.57
Net Intangibles Purchase And Sale
-77.57
0.00
Purchase Of Intangibles
-77.57
0.00
Financing Cash Flow
107.17
+2939.54%
3.53
-69.93%
11.72
-10.25%
13.06
Cash Flow From Continuing Financing Activities
107.17
+2939.54%
3.53
-69.93%
11.72
-10.25%
13.06
Net Issuance Payments Of Debt
-0.22
0.00
0.00
+100.00%
-0.01
Issuance Of Debt
0.00
-100.00%
0.12
Repayment Of Debt
-0.22
0.00
0.00
+100.00%
-0.14
Long Term Debt Issuance
0.00
-100.00%
0.12
Long Term Debt Payments
-0.22
0.00
0.00
+100.00%
-0.14
Net Long Term Debt Issuance
-0.22
0.00
0.00
+100.00%
-0.01
Net Common Stock Issuance
115.67
+2662.19%
4.19
-65.77%
12.23
-9.88%
13.58
Common Stock Payments
0.00
+100.00%
-0.07
Repurchase Of Capital Stock
0.00
+100.00%
-0.07
Proceeds From Stock Option Exercised
1.71
0.00
-100.00%
0.01
-62.38%
0.02
Net Other Financing Charges
-9.98
-1408.44%
-0.66
-27.46%
-0.52
+0.41%
-0.52
Changes In Cash
13.47
+282.67%
-7.38
-266.70%
4.42
-31.99%
6.51
Beginning Cash Position
3.56
-67.45%
10.94
+67.96%
6.51
+149361.29%
0.00
End Cash Position
17.03
+378.53%
3.56
-67.45%
10.94
+67.96%
6.51
Free Cash Flow
-93.70
-759.48%
-10.90
-49.34%
-7.30
-11.32%
-6.56
Interest Paid Supplemental Data
0.03
+107.14%
0.01
-17.09%
0.02
-25.79%
0.02
Change In Interest Payable
0.00
-100.00%
0.01
Common Stock Issuance
115.67
+2662.19%
4.19
-65.77%
12.23
-10.34%
13.65
Issuance Of Capital Stock
115.67
+2662.19%
4.19
-65.77%
12.23
-10.34%
13.65
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category